Clinical Trials Directory

Trials / Completed

CompletedNCT01065233

Pangenomic Study During Alcoholic Cirrhosis

Genetical Predisposition in Hepatocellular Carcinoma : Pangenomic Link Study During Alcoholic Cirrhosis

Status
Completed
Phase
Study type
Observational
Enrollment
1,325 (actual)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
35 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Hepatocellular carcinoma (HCC) is a frequent complication of cirrhosis. Occurrence of HCC could be linked with multiple functional region of genome. The determining of a genomic mapping of " single nucleotide polymorphisms " (SNPs) permit to perform some genetic link studies with pathologies without clear hereditary disposition. In this study, the investigators will identify predictives genetic polymorphism of HCC.

Conditions

Interventions

TypeNameDescription
GENETICDNA extractionDNA extraction of blood sample for DNAship analysis

Timeline

Start date
2008-10-23
Primary completion
2011-12-27
Completion
2013-07-20
First posted
2010-02-09
Last updated
2021-09-17

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01065233. Inclusion in this directory is not an endorsement.

Pangenomic Study During Alcoholic Cirrhosis (NCT01065233) · Clinical Trials Directory